Home Cart Sign in  
Chemical Structure| 134448-10-5 Chemical Structure| 134448-10-5

Structure of CA-074
CAS No.: 134448-10-5

Chemical Structure| 134448-10-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

CA 074 is an inhibitor of cathepsin B with Ki of 2 - 5 nM.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of CA-074

CAS No. :134448-10-5
Formula : C18H29N3O6
M.W : 383.44
SMILES Code : O=[C@](NCCC)[C@H]1O[C@@H]1[C@@](N[C@@H]([C@@H](C)CC)[C@](N2[C@H](C(O)=O)CCC2)=O)=O
MDL No. :MFCD00797531

Safety of CA-074

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of CA-074

pyroptosis

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00856661 Stroke Phase 3 Terminated(The recruitment int... More >>o DIAS4 has been stopped as the result of DIAS 3 indicates that the study is unlikely to reach its primary endpoint with the current protocol) Less << - -
NCT02585934 Alzheimer's Disease Phase 3 Completed - -
NCT02723240 Cancer Phase 1 Recruiting June 30, 2019 United Kingdom ... More >> Belfast City Hospital Not yet recruiting Belfast, United Kingdom, BT9 7AB Principal Investigator: Richard H Wilson, MD          Beatson, West of Scotland Cancer Centre Recruiting Glasgow, United Kingdom, G12 OYN Principal Investigator: Jeffry Evans, MD, FRCP          Oxford University Hospitals NHS Trust Recruiting Oxford, United Kingdom, OX3 7LE Principal Investigator: Sarah P Blagden, Phd, FRCP Less <<
NCT01488240 Burn Scar Not Applicable Recruiting June 2019 Canada, Manitoba ... More >> University of Manitoba Recruiting Winnipeg, Manitoba, Canada, R3A 1R9 Contact: Justin P Gawaziuk, MSc    2047873669    jgawaziuk@hsc.mb.ca    Principal Investigator: Sarvesh Logsetty, MD Less <<
NCT02542826 Pulmonary Disease, Chronic Obs... More >>tructive Less << Not Applicable Recruiting August 2018 Canada, Quebec ... More >> McConnell Centre for Innovative Medicine, Research Institute of the McGill University Health Centre Recruiting Montreal, Quebec, Canada, H4A 3J1 Contact: Dennis Jensen, Ph.D.    514-398-4184 ext 0541    dennis.jensen@mcgill.ca    Principal Investigator: Dennis Jensen, Ph.D. Less <<
NCT03063424 Exercise Induced Bronchospasm Not Applicable Recruiting December 2017 Canada, Quebec ... More >> Université de Sherbrooke Recruiting Sherbrooke, Quebec, Canada, J1G2E8 Contact: Katia Carle-Talbot, MD, resident    514-592-1113 ext pag 0477    katia.carle-talbot@usherbrooke.ca    Contact: Brian Grondin-Beaudoin, MD    819-346-1110 ext 14252    Brian.Grondin.Beaudoin@USherbrooke.ca Less <<
NCT02585934 - Completed - -
NCT01835015 Age-related Macular Degenerati... More >>on Less << Phase 1 Completed - -
NCT01978184 Pancreatic Cancer Phase 2 Active, not recruiting November 2018 United States, Pennsylvania ... More >> Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00856661 - Terminated(The recruitment int... More >>o DIAS4 has been stopped as the result of DIAS 3 indicates that the study is unlikely to reach its primary endpoint with the current protocol) Less << - -
NCT01835015 - Completed - -
NCT00730301 Emphysema Chr... More >>onic Obstructive Pulmonary Disease Less << Phase 4 Unknown - Austria ... More >> Otto Wagner Hospital Recruiting Vienna, Austria, 1140 Contact: Arschang Valipour, MD       arschang.valipour@wienkav.at    Belgium University Antwerp Recruiting Antwerp, Belgium Contact: Paul Germonpre, MD       Paul.Germonpre@uza.be    Principal Investigator: Paul Germonpre, MD          University Brussels Recruiting Brussels, Belgium Contact: Marc Meysman, MD       Marc.Meysman@uzbrussel.be    Principal Investigator: Marc Meysman, MD Less <<
NCT03646149 - Enrolling by invitation August 19, 2019 United States, California ... More >> VA Greater Los Angeles Healthcare System, West Los Angeles, CA West Los Angeles, California, United States, 90073 Less <<
NCT00057135 Schizophrenia ... More >> Schizoaffective Disorder Bipolar Disorder Less << Not Applicable Completed - United States, California ... More >> VA San Diego Healthcare System, San Diego, CA San Diego, California, United States, 92161 United States, Illinois Edward Hines Jr. VA Hospital, Hines, IL Hines, Illinois, United States, 60141-5000 United States, Massachusetts East Orange Campus of the VA New Jersey Health Care System, East Orange, NJ East Orange, Massachusetts, United States, 07018 United States, Michigan VA Ann Arbor Healthcare System, Ann Arbor, MI Ann Arbor, Michigan, United States, 48105 United States, Rhode Island John D. Dingell VA Medical Center, Detroit, MI Detroit, Rhode Island, United States, 48201 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.61mL

0.52mL

0.26mL

13.04mL

2.61mL

1.30mL

26.08mL

5.22mL

2.61mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories